US science funding frozen

The financial crisis befalling the nation has proven that its tentacles reach even into the scientific community. On Saturday (Sept. 27), the US Senate decided to freeze federal funding of any program except those relating to veterans affairs and national security by linkurl:passing;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR02638:@@@X bill linkurl:HR 2638.;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR02638:@@@L&summ2=m& This leaves many US science agencies including NASA, the National In

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The financial crisis befalling the nation has proven that its tentacles reach even into the scientific community. On Saturday (Sept. 27), the US Senate decided to freeze federal funding of any program except those relating to veterans affairs and national security by linkurl:passing;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR02638:@@@X bill linkurl:HR 2638.;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR02638:@@@L&summ2=m& This leaves many US science agencies including NASA, the National Institutes of Health, and the National Science Foundation high and dry for the first half of the 2009 fiscal year. The bill, which received broad bipartisan support in Congress, keeps the budgets of NASA, the NIH, the NSF, and the Department of Energy at current levels from tomorrow - October 1, the beginning of the fiscal year - until March 6, 2009. The passage of this legislation scuttles an attempt to linkurl:boost;http://www.the-scientist.com/blog/display/55016/ the NIH budget by $500 million before the start of the fiscal year as well as linkurl:other;http://www.the-scientist.com/blog/display/54756/ planned NIH budget increases. Only the $150 million linkurl:increase;http://www.the-scientist.com/blog/display/54761/ that the NIH got as part of a supplementary funding bill back in July will stand. Researchers applying for new or continued NIH funding this year will likely feel the pinch in the form of less grant awards and reduced funding levels on existing grants, according to linkurl:__Science__.;http://sciencenow.sciencemag.org/cgi/content/full/2008/929/1 The legislation now goes to President George W. Bush's desk to await his signature.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies